MedTrace Logo

Enhancing Inhibition With tDCS in Low Back Pain

NCT03864822 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2020-12-11

No results posted yet for this study

Summary

This cross-over study intends to use consecutive days of active versus sham transcranial direct current stimulation (tDCS) to enhance descending inhibition and look at resulting clinical effects in people with low back pain.

Conditions

  • Low Back Pain

Interventions

DEVICE

High-Definition Transcranial Direct Current Stimulation

Device uses an array of electrodes over the scalp, in contact via gel, to provide a weak electrical current.

Sponsors & Collaborators

  • Danish National Research Foundation

    collaborator OTHER

  • Aalborg University

    lead OTHER

Principal Investigators

  • Megan E McPhee, BPhty MSc · Center for Neuroplasticity and Pain (CNAP), SMI, Aalborg University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-29
Primary Completion
2020-10-07
Completion
2020-10-07

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03864822 on ClinicalTrials.gov